Marinomed Biotech AG | WebDisclosure

Basculer en Français

11189	Companies
247545	Keywords
175382	Articles
133771	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 07/22/2026 at 14:48, 2 months 25 days ago

Marinomed Biotech AG seeks reorganisation through restructuring proceedings without self-administration
Marinomed Biotech seeks reorganisation through restructuring proceedings without self-administration due to outstanding earn-out payments and terminated negotiations with Unither Pharmaceuticals

Marinomed Biotech Restructuring Proceedings Unither Pharmaceuticals Earn-out Payments Financial Stabilisation
PRESS RELEASE

published on 07/22/2026 at 14:43, 2 months 25 days ago

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
Marinomed Biotech AG files for court restructuring proceedings without self-administration. Market making contract terminated, affecting share liquidity. Half-year financial report postponed

Financial Report Marinomed Biotech AG Market Making Share Liquidity Restructuring Proceedings
BRIEF

published on 07/20/2026 at 15:16, 2 months 27 days ago

Marinomed Biotech AG confrontée à une incertitude financière

Marinomed Biotech AG Restructuration Incertitude Financière Risque D'insolvabilité Paiements De Complément De Prix
BRIEF

published on 07/20/2026 at 15:16, 2 months 27 days ago

Marinomed Biotech AG Faces Financial Uncertainty

Restructuring Marinomed Biotech AG Financial Uncertainty Insolvency Risk Earn-out Payments
PRESS RELEASE

published on 07/20/2026 at 15:11, 2 months 27 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Under Review
First Berlin Equity Research updates rating and price target for Marinomed Biotech AG to UNDER REVIEW, following announcement of court-supervised restructuring proceedings

First Berlin Equity Research Research Update Marinomed Biotech AG Under Review Court-supervised Restructuring
BRIEF

published on 07/20/2026 at 13:27, 2 months 27 days ago

Marinomed Biotech AG confrontée à une restructuration suite à l'échec des négociations

Marinomed Biotech AG Restructuration Remboursement De La Dette Risque D'insolvabilité Recherche Sur Les Actions De First Berlin
BRIEF

published on 07/20/2026 at 13:27, 2 months 27 days ago

Marinomed Biotech AG Faces Restructuring Amid Negotiation Breakdown

First Berlin Equity Research Restructuring Marinomed Biotech AG Debt Repayment Insolvency Risk
PRESS RELEASE

published on 07/20/2026 at 13:22, 2 months 27 days ago

Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Under Review
First Berlin Equity Research GmbH has updated its recommendation and price target on Marinomed Biotech AG (ATMARINOMED6) to UNDER REVIEW following the company's announcement of filing for court-supervised restructuring proceedings to address insolvency risk

Research Update Marinomed Biotech AG First Berlin Equity Research GmbH Insolvency Risk Restructuring Proceedings
BRIEF

published on 07/16/2026 at 23:15, 3 months ago

Marinomed Biotech AG Seeks Court-Approved Restructuring Amid Financial Strains

Marinomed Biotech AG Financial Stability Insolvency Risk Unither Pharmaceuticals Court Restructuring
BRIEF

published on 07/16/2026 at 23:15, 3 months ago

Marinomed Biotech AG demande une restructuration approuvée par le tribunal en raison de difficultés financières

Marinomed Biotech AG Stabilité Financière Risque D'insolvabilité Unither Pharmaceuticals Restructuration Du Système Judiciaire

Accesswire

Published on 10/17/2026 at 03:20, 1 hour 19 minutes ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 hour 24 minutes ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 5 hours 4 minutes ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 5 hours 9 minutes ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 5 hours 39 minutes ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

EQS Group

Published on 10/16/2026 at 20:08, 8 hours 30 minutes ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 9 hours 18 minutes ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 9 hours 33 minutes ago

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 10 hours 20 minutes ago

Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 10 hours 25 minutes ago

EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance

Les Echos

Published on 10/16/2026 at 19:54, 8 hours 44 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 9 hours 50 minutes ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 9 hours 50 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 10 hours 39 minutes ago

KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
Published on 10/16/2026 at 07:30, 21 hours 9 minutes ago

Third Quarter Revenues 2026

View all LES ECHOS COMFI WIRE